Azithromycin 250mg Tablets – Trusted Macrolide Antibacterial Therapy

Introduction

• Azithromycin 250mg Tablets represent a highly relevant product in modern antibacterial therapy.
• Azithromycin belongs to the macrolide antibiotic class and works by inhibiting bacterial protein synthesis, helping stop the growth of susceptible bacteria.
• It is intended for bacterial infections and should not be used for viral illnesses such as the common cold or flu.
• The 250mg strength is commonly used in short-course regimens, including follow-on schedules after a higher first-day dose depending on the indication and physician decision.
• Its relatively long half-life supports once-daily dosing and shorter therapy duration, improving patient adherence in outpatient treatment settings.

Important Information

• Azithromycin 250mg Tablets are used only when a bacterial infection is proven or strongly suspected.
• The product is valued for broad clinical familiarity, convenient dosing, and strong patient compliance.
• The active ingredient is Azithromycin with CAS number 83905-01-5, an important identifier for technical and procurement documentation.
• The relatively long half-life of azithromycin supports short-course therapy and sustained tissue activity.
• Buyers and distributors typically expect consistent assay, dissolution, stability, and packaging integrity for this formulation.

Storage

• Store in a cool, dry place
• Protect from moisture and direct sunlight
• Keep in original blister or container until use
• Keep out of reach of children
• Follow the approved label storage condition for the destination market

Shelf Life

• Shelf life depends on the manufacturer’s validated stability data, packaging system, and approved registration dossier
• Shelf life is established through formal stability studies under recognized guidelines
• Use the labeled expiry date on the approved commercial pack
• Follow approved stability data for market-specific shelf life

Dosage

Manufacturing

• Produced under stringent pharmaceutical quality controls
• Qualified API sourcing linked to CAS 83905-01-5
• Controlled blending, granulation, or direct compression as applicable
• Tablet uniformity and assay consistency
• Dissolution compliance
• Microbiological and stability controls
• Tamper-evident and export-suitable packaging
• Batch traceability and documentation support

Precautions

• Use only for bacterial infections when clinically appropriate
• Use with caution in patients with liver impairment or history of hepatic problems
• Use with caution in patients with QT prolongation risk, arrhythmias, or those taking QT-prolonging medicines
• Patients with a history of serious allergy to macrolide antibiotics require careful medical review
• The full prescribed course should usually be completed to support effective antibacterial treatment

Side Effects

• Nausea
• Diarrhea or loose stools
• Abdominal pain
• Vomiting
• Rash in some cases
• Taste changes
• Rare but serious allergic reactions
• Possible liver-related issues
• Possible cardiac rhythm concerns in susceptible patients

Expert View

• Azithromycin 250mg Tablets remain highly relevant in modern antibacterial therapy because of strong patient compliance, broad clinical familiarity, and convenient dosing.
• The 250mg strength is commercially important in many regulated and semi-regulated markets due to its role in short-course and step-down regimens.
• Its long half-life is a major pharmacokinetic advantage that supports once-daily dosing and better treatment adherence.
• From a product-page perspective, strong documentation, batch traceability, and reproducible manufacturing quality are critical for international buyers.
• Azithromycin 250mg Tablets remain a commercially serious and globally recognized antibacterial formulation.

Indications

• Respiratory tract infections
• Bronchitis
• Pneumonia
• Ear infections
• Nose infections
• Throat infections
• Skin and soft tissue infections
• Certain sexually transmitted infections
• Mild to moderate susceptible bacterial infections

Maintenance

• Take once daily exactly as prescribed
• Complete the full prescribed antibacterial course
• Do not stop early unless advised by a doctor
• Monitor response to treatment during the therapy period
• Use only for confirmed or strongly suspected bacterial infections
• Store in original packaging and protect from moisture
• Follow approved labeling and destination-market storage instructions

Why Choose

• Short-course therapy potential
• Once-daily dosing convenience
• Strong patient compliance profile
• Broad international clinical familiarity
• Export-relevant documentation and batch traceability
• Suitable for regulated pharmaceutical distribution